Abstract:Introduction. The human genome consists of roughly 30,000 genes coding for over 500,000 different proteins, of which more than 10,000 proteins can be produced by the cell at any given time (the cellular “proteome”). It has been estimated that over 80% of proteins do not operate alone, but in complexes. These protein-protein interactions (PPI) are regulated by several mechanisms. For example, post-translational modifications (methylation, acetylation, phosphorylation, or ubiquitination) or metal-binding can lead to conformational changes that alter the affinity and kinetic parameters of the interaction. Many PPIs are part of larger cellular networks of interactions or interactomes. Indeed, these interactions are at the core of the entire interactomics system of any living cell, and so, aberrant PPIs are the basis of multiple diseases, such as neurodegenerative diseases and cancer. The objective of this study was to develop a method of monitoring protein-protein interactions and proximity dependence in vivo.Methods. The biotin ligase BirA was fused to the protein of interest, and the Biotin Acceptor Peptide (BAP) was fused to an interacting partner to make the detection of its biotinylation possible by western blot or mass spectrometry.Results. Using several experimental systems (BirA.A + BAP.B), we showed that the biotinylation is interaction/proximity dependent. Here, A and B are the next nuclear proteins used in the experiments – 3 paralogues of heterochromatin protein HP1a (CBX5), HP1b (CBX1), HP1g (CBX3), wild type and transcription mutant factor Kap1, translesion DNA polymerase PolH and E3, ubiquitin ligase RAD18, Proliferative Cell Nuclear Antigen (PCNA), ubiquitin Ub, SUMO-2/3, different types and isoforms of histones H2A, H2Az, H3.1, H3.3, CenpA, H2A.BBD, and macroH2A. The variant of this approach is termed PUB-NChIP (Proximity Utilizing Biotinylation with Native Chromatin Immuno-precipitation) and is designed to purify and study the protein composition of chromatin in proximity to the nuclear protein of interest. Using the RAD18 protein as a model, we demonstrated that the RAD18-proximal chromatin is enriched in some H4 acetylated species. Moreover, the RAD18-proximal chromatin containing a replacement histone H2Az has a different pattern of H4 acetylation.Conclusion. Progress in the last decade in cancer drug therapy has led us to the conclusion that the nucleus of eukaryotic cells is an active site for many cellular processes important to the development of cancer. These processes include changes in genetic and epigenetic landscape (e. g. methylation of DNA, modification of histones) and the expression levels of transcription factors, which regulates gene products (e.g. hypoxia-inducible factor 1α (HIF-1α) in chronic anemia, etc.) where protein-protein interactions play important role. Understanding the nature of protein-protein interactions may improve design strategies for small-molecule PPI modulators. PPI assay technologies that closely reflect physiological conditions hold the key to developing specific anti-cancer drugs.

Development and Validation of a Proximity Labeling Fusion Protein Construct to Identify the Protein-Protein Interactions of Transcription Factors

Genetically Encoded Protein Photocrosslinker with a Transferable Mass Spectrometry-Identifiable Label

Novel High-Throughput Profiling of Human Transcription Factors and Its Use for Systematic Pathway Mapping

Proximity-based labelling for proteomic mapping

Photoaffinity Labeling Of Transcription Factors By Dna-Templated Crosslinking

Proteome-wide Profiling of Activated Transcription Factors with a Concatenated Tandem Array of Transcription Factor Response Elements.

Switchable DNA Catalysts for Proximity Labeling at Sites of Protein-Protein Interactions

Deciphering molecular interactions by proximity labeling

Deciphering the Interactome of Histone Marks in Living Cells via Genetic Code Expansion Combined with Proximity Labeling

A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells

Super-resolution proximity labeling with enhanced direct identification of biotinylation sites

A Microfluidics-Based Platform For Identification And Detailed Characterization Of Transcription Factor Binding Sites

Proximity Utilizing Biotinylation of Nuclear Proteins in vivo

Application of Twin‐Strep Tagging and TurboID Proximity Labeling in Discovery of Microprotein‐protein Interactions

Subcellular Interactomes Revealed by Merging APEX with Cross-Linking Mass Spectrometry

Defining dynamic protein interactions using SILAC-based quantitative mass spectrometry.

Exploring Options for Proximity-Dependent Biotinylation Experiments: Comparative Analysis of Labeling Enzymes and Affinity Purification Resins

Hi-Tag: a simple and efficient method for identifying protein-mediated long-range chromatin interactions with low cell numbers

The development of proximity labeling technology and its applications in mammals, plants, and microorganisms

Proximity Labeling in Plants

Spatiotemporal and global profiling of DNA–protein interactions enables discovery of low-affinity transcription factors